Offer - Urjas Oil for just ₹ 1
Gefticip Tablet (30) is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Gefticip Tablet (30) safe for pregnant women?
Gefticip has many dangerous side effects in pregnant women. If you are pregnant, do not consume Gefticip without medical advice.
Is the use of Gefticip Tablet (30) safe during breastfeeding?
Gefticip may cause serious side effects in breastfeeding women, so do not take this drug without doctor's advice.
What is the effect of Gefticip Tablet (30) on the Kidneys?
Gefticip rarely harms the kidneys.
What is the effect of Gefticip Tablet (30) on the Liver?
Very few cases of side effects of Gefticip on the liver have been reported.
What is the effect of Gefticip Tablet (30) on the Heart?
Gefticip is not harmful for the heart.
If you are suffering from any of the following diseases, you should not take Gefticip Tablet (30) unless your doctor advises you to do so -
Is this Gefticip Tablet (30) habit forming or addictive?
Gefticip Tablet (30) does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
After taking Gefticip Tablet (30) you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Gefticip Tablet (30) is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, Gefticip Tablet (30) is not used to treat mental disorders.
Interaction between Food and Gefticip Tablet (30)
Taking Gefticip Tablet (30) with food does not cause any problems.
Interaction between Alcohol and Gefticip Tablet (30)
No research has been done on this till date. Therefore, it is not known what the effect of taking Gefticip Tablet (30) with alcohol will be.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Iressa (gefitinib tablets)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 870
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 610-612